menu
https://novonordiskfonden.dk/da/events/future-of-precision-medicine-symposium-2021/

Future of Precision Medicine Symposium 2021

Future of Precision Medicine Symposium 2021

Location: Virtual or in-person attendance Hellerup/Denmark
22 Nov 2021

The discovery of insulin 100 years ago was a true breakthrough and lifesaver in the treatment of people with diabetes. However, despite being around for a century, insulin and other means of treatment, often deployed in a one-size-fits-all manner, still fail to take most people to a level of control that normalizes morbidity and mortality. Precision medicine, the tailoring of disease prevention and treatment strategies based on an individual’s genetics and other biomarkers, lifestyle and environment, aims at doing just that, by helping optimise medical decisions. 

This two-day symposium on the future of precision medicine will feature lectures and panel discussions on precision diagnostics, precision prevention, pediatric precision medicine, clinical implementation, health disparities, the power of big data, patient perspectives, and policy and implementation, with a focus on the opportunities and barriers for the implementation of precision medicine in research and practice.  

The symposium will also celebrate the winner of the EFSD and Novo Nordisk Foundation Precision Diabetes Medicine Award. The award honours innovative research in both clinical and basic science that are likely to minimise the future burden of diabetes and other chronic disease. 

Hybrid symposium
The event is planned as a hybrid symposium, with both online and in-person attendance at the Novo Nordisk Foundation in Hellerup, Denmark. In person attendance will be dependent on the COVID-19 situation and Danish Government restrictions.

Topics 

  • Sessions on precision prevention, precision diagnostics, pediatric precision medicine, clinical implementation, global partnerships in precision diabetes medicine, diversity and disparity, and strength in numbers 
  • Panel discussions on precision medicine in society: possibilities and challenges 
  • Award lectures from the winner and runners up of the European Foundation for the Study of Diabetes and Novo Nordisk Foundation Precision Diabetes Medicine Award 
Speakers and panelists
  • Professor Ruth Loos, University of Copenhagen, Denmark
  • Professor Eran Segal, Weizmann Institute of Science, Israel
  • Professor Andrew Hattersley, University of Exeter, UK
  • Professor Carla Greenbaum, Benaroya Research Institute, USA
  • Associate Professor Marie-France Hivert, Harvard Medical School, USA
  • Professor Ewan Pearson, University of Dundee, UK
  • Professor Sir Stephen O’Rahilly, University of Cambridge, UK
  • Dr Giles Yeo, University of Cambridge, UK
  • Professor Louis H. Phillipson, University of Chicago, American Diabetes Association, USA
  • Chief Medical Officer, Dr. Michael Lynge Pedersen, Steno Diabetes Center Greenland
  • Professor Torben Hansen, Novo Nordisk Foundation Center for Basic Metabolic Research (CBMR), University of Copenhagen, Denmark
  • Dr. V Mohan, Diabetology, Dr. Mohan’s Diabetes Specialities Centre, Madras Diabetes Research Foundation, India
  • Professor Søren Brunak, University of Copenhagen, Denmark
  • Professor Daniel Witte, Steno Diabetes Center Aarhus, Denmark
  • Professor Jose C. Florez, Massachusetts General Hospital, USA
  • CEO Henrik Ullum, Statens Serum Institut, Denmark
  • CEO Bettina Lundgren, Danish National Genome Center, Denmark
  • Mr. Christian Collins, Copenhagen, Denmark
  • CEO Mads Krogsgaard Thomsen, NNF

More to be announced

Tentative programme

Monday, 22 November


Official opening

Welcome and opening remarks
SVP Martin Ridderstråle, NNF
President Stefano Del Prato, EFSD 
Professor Hindrik Mulder, Diabetologia, Lund University 

Theme I: Precision prevention
Lecture: Professor Ruth Loos, University of Copenhagen 
Sub-theme: Genetic subclassification of obesity in diabetes prevention

Lecture: Professor Eran Segal, Weizmann Institute of Science  
Sub-theme: Precision nutrition in diabetes prevention and management
Q&A facilitated by: To Be Confirmed

Theme II: Precision diagnostics
Lecture: Professor Andrew Hattersley, University of Exeter
Sub-theme: Monogenic
Lecture: To Be Confirmed
Sub-theme: To Be Confirmed
Q&A facilitated by: To Be Confirmed

Theme III: Pediatric precision medicine
Lecture: Professor Carla Greenbaum, Benaroya Research Institute, Virgin Mason
Sub-theme: Is there a pediatric endotype in T1D?
Lecture: Associate Professor Marie-France Hivert, Harvard Medical School
Sub-theme: To Be Confirmed
Q&A facilitated by Arne Astrup, NNF

Theme IV: Clinical implementation
Lecture: Professor Ewan Pearson, University of Dundee
Sub-theme: Beyond genetics: optimization of diabetes therapy
Lecture: Professor Sir Steve O’Rahilly, University of Cambridge 
Sub-theme: Genetics in the treatment of obesity
Q&A facilitated by Martin Ridderstråle, NNF

Panel discussion: Precision medicine in society: possibilities and challenges
Panelists and the final sub-theme to be confirmed. 

Award-program. Chair: Professor Michael Roden, EFSD
Award Ceremony
Prize Lecture: Winner of the EFSD and Novo Nordisk Foundation Precision Diabetes Medicine Award

Dinner for in-person attendees
Pre-dinner lecture: Dr Giles Yeo, University of Cambridge
Dinner

Tuesday, 23 November


Runner-up Awardees.
Chair: Professor Michael Roden, EFSD
Lecture: Runner-up of the EFSD and Novo Nordisk Foundation Precision Diabetes Medicine Award
Lecture: Runner-up of the EFSD and Novo Nordisk Foundation Precision Diabetes Medicine Award

Theme V: Global partnerships in precision diabetes medicine
Lecture: Professor Louis H. Philipson, University of Chicago, American Diabetes Association 
Sub-theme: The ADA/EASD Precision Medicine in Diabetes Initiative
Lecture: To Be Confirmed
Sub-theme: To Be Confirmed
Q&A facilitated by Professor Jose C Florez, Massachusetts General Hospital

Theme VI: Diversity and disparity
Introduction by Chief Medical Officer Michael Lynge Pedersen, Steno Diabetes Center Greenland
Lecture: Professor Torben Hansen, Novo Nordisk Foundation Center for Basic Metabolic Research (CBMR), University of Copenhagen 
Sub-theme: Lessons in precision diabetes medicine from Greenland’s Inuit
Lecture: To Be Confirmed
Sub-theme: To Be Confirmed
Q&A facilitated by Professor Marit Eika Jørgensen, Steno Diabetes Center Greenland

Theme VII: Strength in numbers
Lecture: Professor Soren Brunak, University of Copenhagen 
Sub-theme: Data lakes, data mountains, and data mining  
Lecture: To Be Confirmed
Q&A facilitated by Paul Franks, NNF 

Panel discussion: Precision medicine in society: possibilities and challenges  
Panelists and the final sub-theme to be confirmed. 

Official closing
SVP Martin Ridderstråle, NNF  
President Stefano Del Prato, EFSD  
Professor Hindrik Mulder, Diabetologia, Lund University 

 

Registration
Register to attend here. 

Registration will be free of charge but required if you would like to attend. Attendees have the option to select “in person attendance preferred”. Attendees who can attend in person will be notified closer to the event. In person attendance will be on a first come, first served basis, and is dependent on Danish Government restrictions. 

Contact person: Charlotte Hinge, ckhi@novo.dk  

Register here